Condition (MeSH)
Urinary Bladder, Underactive
ClinicalTrials.gov lists 30 trials for Urinary Bladder, Underactive or a narrower condition beneath it. Taichung Armed Forces General Hospital has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
30 of the 30 trials are tagged with Urinary Bladder, Underactive itself; the rest are tagged with a narrower condition beneath it.
When did Urinary Bladder, Underactive trials start? (17)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 2/3
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2024 | 2 |
| 2023 | 2 |
| 2022 | 1 |
| 2021 | 4 |
| 2020 | 2 |
| 2019 | 4 |
| 2018 | 2 |
| 2017 | 3 |
Showing 10 of 17 earlier years.
No forecast is made for this condition: it averages 1.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Urinary Bladder, Underactive trials in? (6)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 2/3 | 1 |
| Phase 4 | 1 |
| Not applicable | 15 |
| Observational | 10 |
How many Urinary Bladder, Underactive trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 1 |
| Completed | 22 |
| Terminated | 1 |
| Unknown status | 4 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Urinary Bladder, Underactive trials? (5)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Taichung Armed Forces General Hospital | 2 |
| Astellas Pharma Europe B.V. | 1 |
| ConvaTec Inc. | 1 |
| EEPiDuDa Study Group | 1 |
| Iota Biosciences, Inc | 1 |
Which drugs are being tested for Urinary Bladder, Underactive? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Pyridostigmine | 1 |
| ASP8302 | 1 |
| Tamsulosin | 1 |
Interventions as named in the registry (8)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Plain aqueous gel | 2 |
| Lidocaine Gel | 2 |
| TAC-302 | 1 |
| Hyperbaric Oxygen | 1 |
| Uroflowmetry(Group B) | 1 |
Showing 5 of 8 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Urinary Bladder, Underactive trials report? (8)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Aortic stenosis | 1 | 1 |
| Closed fracture of tibia | 1 | 1 |
| Diverticulum intestinal haemorrhagic | 1 | 1 |
| Fracture of Humerus | 1 | 1 |
| Fracture of femoral neck | 1 | 1 |
Showing 5 of 8 adverse events.
Which publications cover Urinary Bladder, Underactive? (14)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Muscarinic-3-receptor positive allosteric modulator ASP8302 in patients with underactive bladder. A randomized controlled trial. | Neurourology and urodynamics | 2022 | Yes |
| Efficacy of TAC-302 for patients with detrusor underactivity and overactive bladder: a randomized, double-blind, placebo-controlled phase 2 study. | World journal of urology | 2022 | Yes |
| Clinical diagnostic criteria for detrusor underactivity: A report from the Japanese Continence Society working group on underactive bladder. | Lower urinary tract symptoms | 2021 | Yes |
| Therapeutic effect of Low intensity Extracorporeal Shock Wave Therapy (Li-ESWT) on diabetic bladder dysfunction in a rat model. | International journal of medical sciences | 2021 | Yes |
| Long-term functional change of cryoinjury-induced detrusor underactivity and effects of extracorporeal shock wave therapy in a rat model. | International urology and nephrology | 2019 | Yes |
Showing 5 of 14 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.